Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety And Efficacy Of Empagliflozin In Pakistani Muslim Population With Type Ii Diabetes Mellitus

NCT04665284 is registered in ClinicalTrials.gov with Getz Pharma as lead sponsor.

NCT NCT04665284
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04665284 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety And Efficacy Of Empagliflozin In Pakistani Muslim Population With Type Ii Diabetes Mellitus
Lead sponsor
Getz Pharma
Phase
Phase 4
Overall status
Completed
Start date
June 1, 2019
Completion date
September 28, 2020
Enrollment
244 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

type ii diabetes mellitus